INVENTORIES



(Dollars in Millions)	October 1, 2017		January 1, 2017
Raw materials and supplies	$	1,141	952
Goods in process	2,388		2,185
Finished goods	5,992		5,007
Total inventories	$	9,521	8,144

Inventory of $63 million was classified as held for sale, and reported in prepaid expenses and other on the Consolidated Balance Sheet, related to the divestiture of the Codman Neurosurgery business which was pending as of October 1, 2017.

See Note 10 to the Consolidated Financial Statements for additional details on inventory related to the Actelion acquisition.